Literature DB >> 15515004

Aversive stimulation of the inferior colliculus changes dopamine and serotonin extracellular levels in the frontal cortex: modulation by the basolateral nucleus of amygdala.

Carlos Eduardo Macedo1, Gabriel Cuadra, Victor Molina, Marcus L Brandão.   

Abstract

We have shown that stimulation of the neural substrates in the inferior colliculus (IC) causes a significant increase in the extracellular levels of dopamine (DA) in frontal cortex (FC). Also, it has been reported that the basolateral complex of the amygdala (BLA) serves as a filter for unconditioned and conditioned aversive information that ascend to higher structures from the brainstem. Linking these two kinds of information, this work examines whether inactivation of BLA interferes with the activation of cortical dopaminergic outputs produced by aversive stimulation of the IC. To this end, rats were implanted with an electrode in the IC for the determination of the threshold of escape responses. Each rat also bore a cannula implanted in the BLA for injections of lidocaine (10 microg/0.5 microL), muscimol (0.5 microg/0.5 microL), or its vehicle and a microdialysis probe in the FC for determination of the amount of DA and serotonin (5-HT). The data obtained show that IC electrical stimulation caused an increase in the DA release while it reduced the 5-HT release in the FC. BLA inactivation with both lidocaine or muscimol enhanced the aversiveness of the electrical stimulation of the IC and attenuated the increase in DA, while the reduction in 5-HT release in the FC remained unaffected. These findings suggest that ascending aversive information from IC on their way up to higher structures in the SNC courses with opposite modulation by DA/5-HT mechanisms in the FC. These processes are regulated by filters located in the BLA. It is proposed that the loss of these BLA regulatory mechanisms prevents the expression of these modulatory mechanisms in the FC that are adaptive responses in order to cope with unconditioned aversive stimulus triggered at the brainstem level. copyright (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15515004     DOI: 10.1002/syn.20094

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  7 in total

1.  Musicians' enhanced neural differentiation of speech sounds arises early in life: developmental evidence from ages 3 to 30.

Authors:  Dana L Strait; Samantha O'Connell; Alexandra Parbery-Clark; Nina Kraus
Journal:  Cereb Cortex       Date:  2013-04-18       Impact factor: 5.357

2.  Emotion and the auditory brainstem response to speech.

Authors:  Jade Q Wang; Trent Nicol; Erika Skoe; Mikko Sams; Nina Kraus
Journal:  Neurosci Lett       Date:  2009-12-16       Impact factor: 3.046

3.  Emotion modulates early auditory response to speech.

Authors:  Jade Wang; Trent Nicol; Erika Skoe; Mikko Sams; Nina Kraus
Journal:  J Cogn Neurosci       Date:  2009-11       Impact factor: 3.225

4.  Generous economic investments after basolateral amygdala damage.

Authors:  Jack van Honk; Christoph Eisenegger; David Terburg; Dan J Stein; Barak Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

5.  Dopamine D2 receptors in the expression and extinction of contextual and cued conditioned fear in rats.

Authors:  Vivian M de Vita; Heloisa R Zapparoli; Adriano E Reimer; Marcus L Brandão; Amanda R de Oliveira
Journal:  Exp Brain Res       Date:  2021-04-22       Impact factor: 1.972

6.  Hypervigilance for fear after basolateral amygdala damage in humans.

Authors:  D Terburg; B E Morgan; E R Montoya; I T Hooge; H B Thornton; A R Hariri; J Panksepp; D J Stein; J van Honk
Journal:  Transl Psychiatry       Date:  2012-05-15       Impact factor: 6.222

7.  Dissociated neurons and glial cells derived from rat inferior colliculi after digestion with papain.

Authors:  Odett Kaiser; Pooyan Aliuos; Kirsten Wissel; Thomas Lenarz; Darja Werner; Günter Reuter; Andrej Kral; Athanasia Warnecke
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.